Novo Nordisk A/S is a global healthcare company, primarily focused on the research, development, and production of medications for diabetes, obesity, and other chronic diseases.
Novo Nordisk A/S Sustainability Performance
Climate
68%
Renewable Energy
Novo Nordisk A/S obtains 63,2% of its energy from renewable energies. Target value per method: min. 100%
Greenhouse Gas Emissions
Novo Nordisk A/S emits 25% of its CO₂ budget of 365,720 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Supply Chain
Taking into account the entire supply chain, Novo Nordisk A/S emits 10,5 times its CO₂ budget of 365,720 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Recycling and Recovery of Waste
Novo Nordisk A/S recycles 77,8% of its waste. Target value per method: min. 75%
Society
50%
Union Formation and Collective Bargaining Power
No data available for Novo Nordisk A/S. Target value per method: min. 80%
CEO Pay Ratio
CEO Lars Fruergaard Jørgensen earns 83 times the average salary of employees. Target value per method: max. 20 times
Employee Turnover Rate
Novo Nordisk A/S has an employee turnover rate of 5,5%. Target value per method: max. 10%
Harassment and Discrimination at the Workplace
Novo Nordisk A/S meets 3 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria
Gender
70%
Women on Board
Novo Nordisk A/S has 34,8% women across its top leadership and supervisory bodies. Target value per method: min. 40%
Gender Pay Gap
No data available for Novo Nordisk A/S. Target value per method: max. 3%
Women in Management
Novo Nordisk A/S employs 41% female managers. Target value per method: min. 40%
Glass Ceiling
The proportion of women in senior management at Novo Nordisk A/S is 83,7% of the proportion of women in the overall workforce. Target value per method: min. 90%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
Renewable Energy
Novo Nordisk A/S obtains 63,2% of its energy from renewable energies. Target value per method: min. 100%
Greenhouse Gas Emissions
Novo Nordisk A/S emits 25% of its CO₂ budget of 365,720 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Supply Chain
Taking into account the entire supply chain, Novo Nordisk A/S emits 10,5 times its CO₂ budget of 365,720 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget
Waste Recycling
Novo Nordisk A/S recycles 77,8% of its waste. Target value per method: min. 75%
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
No data
We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.
Look at that!
I checked the impact of this company
Novo Nordisk A/S
DK0060534915
Sustainable [100]
Almost sustainable [67-99]
Moderate [34-66]
Not sustainable [0-33]
powered by
www.moneycare.io
Compare Novo Nordisk A/S with ...
Novo Nordisk A/S
?
Impact Score
Climate
Society
Gender
68%
50%
70%
0%
0%
0%
Novo Nordisk A/S
?
Impact Score
Climate
Renewable Energy
63%
Greenhouse Gas Emissions
100%
Supply Chain
10%
Waste Recycling
100%
Society
Collective Agreements
—
CEO Pay Ratio
24%
Employee Turnover Rate
100%
Anti-Discrimination
75%
Gender
Women on Board
87%
Gender Pay Gap
—
Women in Management
100%
Glass Ceiling
93%
Sources of sustainability performance
Metric
Value
Unit
Year
PDF Name
PDF Page
No sources found.
Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.